Clinical Trial Update: Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pegfilgrastim and darbepoetin alfa as supportive care in adjuvant chemotherapy for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Harold J. Burstein, MD, PhD | Conditions: Breast Cancer, Stage I Breast Cancer | Phase 2 | Status: COMPLETED